Work

Prefrontal Coexpression of Schizophrenia Risk Genes Is Associated With Treatment Response in Patients

Year: 2019

Type: article

Study design: Observational Study

Source: Biological Psychiatry

DOI: 10.1016/j.biopsych.2019.03.981

Authors: Giulio Pergola, Pasquale Di Carlo, Andrew E. Jaffe, Marco Papalino, Qiang Chen, Thomas M. Hyde, Joel E. Kleinman, Joo Heon Shin, Antonio Rampino, Giuseppe Blasi, Daniel R. Weinberger, Alessandro Bertolino

Institutions: Johns Hopkins University, Lieber Institute for Brain Development, University of Bari Aldo Moro, Johns Hopkins Medicine, Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari, Johns Hopkins Hospital

Language: English

Topic: Schizophrenia research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Eli Lilly and Company, Pfizer, AstraZeneca, Yale University, Biogen, University of Southern California, Duke University, F. Hoffmann-La Roche, University of Rochester, Lieber Institute for Brain Development, Fondazione CON IL SUD, Horizon 2020 Framework Programme, Horizon 2020, National Institute of Mental Health, Janssen Pharmaceuticals, H2020 Marie Skłodowska-Curie Actions

Awards: G1519962528, IdentiFication of brain deveLopmental gene co-expression netwOrks to Understand RIsk for SchizopHrenia, G8700482840

OpenAlex ID: W2950724857

FWCI: 3.579

Cites: 116

Cited by: 40

Related to: 10